Last reviewed · How we verify
NCT06150274: CROSSVal
Comparison of Wire Assisted Percutaneous Balloon Mitral Valvulotomy With Standard Inoue Balloon Valvulotomy
NA trial testing Percutaneous Balloon Mitral Valvulotomy in Rheumatic Heart Disease in 20 participants. Completed in 3 June 2024.
31 May 2024
Quick facts
| Lead sponsor | Helse Stavanger HF |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 20 |
| Start date | 24 May 2024 |
| Primary completion | 31 May 2024 |
| Estimated completion | 3 June 2024 |
| Sites | 1 location across Ethiopia |
Drugs / interventions tested
- Percutaneous Balloon Mitral Valvulotomy
Conditions studied
- Rheumatic Heart Disease — all drugs for Rheumatic Heart Disease →
Sponsor
Helse Stavanger HF — full company profile →
Who can join
18 and older, any sex, with Rheumatic Heart Disease. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The goal of this randomised study is comparison of wire assisted balloon mitral valvulotomy to standard Inoue balloon technique on patients with rheumatic mitral stenosis. The main question it aims to answer is whether procedure time is reduced using the wire assisted method. Participants will be randomized to one of the two methods.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Novel Wire-Assisted Mitral Commissurotomy Reduces Valve Crossing Time Compared to Inoue-Balloon Technique of Treating Mitral Stenosis, Randomized Controlled Trial (CROSSVal).
Oljira CF, Packer EJ, Dalen H, Omdal TR, et al · · 2026 · cited 1× · PMID 41264792 · DOI 10.1002/ccd.70343
Verify or expand the search:
- PubMed search for NCT06150274
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Rheumatic Heart Disease
Currently open trials in the same condition.
- NCT06952374 — Treating Severe Mitral Valve Annular or Valvular Calcification Using Shockwave Balloon SMARTWAVE · NA · recruiting
- NCT05783375 — Accelerating Delivery of rheUmatic Heart Disease Preventive iNterventions in Northern Uganda · NA · recruiting
- NCT05693545 — GOALIE: Intramuscular vs. Enteral Penicillin Prophylaxis to Prevent Progression of Latent RHD Trial · Phase 2 · active not recruiting
- NCT05991219 — Screening and Secondary Prevention Rheumatic Heart Disease Study · recruiting
- NCT05504928 — Effectiveness of a School-centered Prevention Program on Prevalence of Latent Rheumatic Heart Disease · NA · recruiting
Other Helse Stavanger HF trials
Trials by the same sponsor.
- NCT06983002 — Bridging Affect Consciousness, Mentalization and Trauma- Exploring an Integrative Treatment Approach for Personality Dis · NA · not yet recruiting
- NCT06774261 — Phenserine on the Alzheimer's Treatment Horizon, Study 1 · Phase 1 · not yet recruiting
- NCT06362707 — Fasudil Trial for Treatment of Early Alzheimer's Disease (FEAD) · Phase 2 · recruiting
- NCT06211907 — Small Macular Holes Treated With Air · NA · recruiting
- NCT06115200 — Norwegian Adult Mental Health Registry · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06150274 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Helse Stavanger HF
- Last refreshed: 20 June 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06150274.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing